Stocks to sell

Ocugen, Inc. (NASDAQ:OCGN) is a clinical-stage biopharmaceutical company struggling to find a direction and a bottom in 2022 as the pandemic persists. Investors looking to buy OCGN stock have several tough questions to ask and need straightforward answers to evaluate its shares. Source: shutterstock.com/PhotobyTawat I have written three articles on OCGN stock. I covered two
0 Comments
Clover Health (NASDAQ:CLOV) was supposed to be one of Chamath Palihapitiya’s biggest special purpose acquisition company (SPAC) wins. When Palihapitiya announced plans to take Clover public, traders gravitated to the play as a natural fit. The idea? CLOV stock would upend the sleepy health insurance industry with a big dose of Silicon Valley expertise. Source:
0 Comments
I recently wrote a bullish column on DoorDash (NYSE:DASH) stock, so I’m certainly not bearish on all delivery names. However, there are two very important differences between DASH stock and Grab Holdings (NASDAQ:GRAB) stock. Source: Hafiz Johari / Shutterstock.com Specifically, Grab operates in countries with much weaker economies and lower standards of living than DoorDash.
0 Comments
Faux-meat company Beyond Meat (NASDAQ:BYND) was one of 2020’s stars. But after topping out at $221 in January 2021, BYND stock has lost nearly three-quarters of its value. Source: Nina Firsova / Shutterstock.com Shares have been in a consistent downtrend since late June, while BYND stock has become one of the most shorted stocks in
0 Comments
At first glance, California-headquartered life-sciences company Bionano Genomics (NASDAQ:BNGO) might seem like a good business to invest in. After all, BNGO stock is cheap and that is what traders should look for, right? Source: Dennis Diatel / Shutterstock.com The important lesson here is to avoid confusing “cheap” with “good.” As the old Benjamin Graham/Warren Buffett saying
0 Comments
Digital Turbine (NASDAQ:APPS) and its investors have been on quite a journey since the company listed as a penny stock in July 2006. I think it’s safe to say that APPS stock provides testimony that multi-baggers can occur from the most niche of domains. Source: Shutterstock However, the past is the past, and APPS stock
0 Comments
Life sciences equipment manufacturer Bionano Genomics (NASDAQ:BNGO) was a popular meme stock last year. Consequently, its management raised a massive amount of cash through equity offerings. However, it has failed to sustain investor interest, as its flagship optimal genome mapping tool Saphyr hasn’t gained much traction in the medical community. It continues to grow at
0 Comments
QuantumScape (NYSE:QS) is a speculative pre-revenue stage company operating in the next-generation electric battery industry. The company claims to have advanced technology that could represent a great leap forward in electric battery performance. However, short sellers published scathing criticisms of QuantumScape’s technology and management team last year, leading to a massive decline. QS stock is
0 Comments
It’s been just over a year since traders on Reddit’s WallStreetBets incited the GameStop (NYSE:GME) trading frenzy and the term “meme stock” entered our lexicon. Early on, this retail army also set its sights on struggling movie theater chain AMC Entertainment (NYSE:AMC). An initial short squeeze in early 2021 took AMC stock from around $2
0 Comments